imedix limited

Dissolved 

imedix limited Company Information

Share IMEDIX LIMITED

Company Number

08051021

Directors

Adam Zafar

Shareholders

adam zafar

Group Structure

View All

Industry

Wholesale of pharmaceutical goods

 

Registered Address

2-4 eastern road, romford, essex, RM1 3PJ

imedix limited Estimated Valuation

£514.8k

Pomanda estimates the enterprise value of IMEDIX LIMITED at £514.8k based on a Turnover of £1.2m and 0.45x industry multiple (adjusted for size and gross margin).

imedix limited Estimated Valuation

£0

Pomanda estimates the enterprise value of IMEDIX LIMITED at £0 based on an EBITDA of £-26.1k and a 4.5x industry multiple (adjusted for size and gross margin).

imedix limited Estimated Valuation

£376.4k

Pomanda estimates the enterprise value of IMEDIX LIMITED at £376.4k based on Net Assets of £196.3k and 1.92x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Imedix Limited Overview

Imedix Limited is a dissolved company that was located in essex, RM1 3PJ with a Companies House number of 08051021. It operated in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in April 2012, it's largest shareholder was adam zafar with a 100% stake. The last turnover for Imedix Limited was estimated at £1.2m.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Imedix Limited Health Check

Pomanda's financial health check has awarded Imedix Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3out of 5
positive_score

2 Strong

positive_score

3 Regular

positive_score

6 Weak

size

Size

annual sales of £1.2m, make it smaller than the average company (£21.9m)

£1.2m - Imedix Limited

£21.9m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -14%, show it is growing at a slower rate (5.3%)

-14% - Imedix Limited

5.3% - Industry AVG

production

Production

with a gross margin of 26.5%, this company has a comparable cost of product (26.5%)

26.5% - Imedix Limited

26.5% - Industry AVG

profitability

Profitability

an operating margin of -2.7% make it less profitable than the average company (3.6%)

-2.7% - Imedix Limited

3.6% - Industry AVG

employees

Employees

with 2 employees, this is below the industry average (47)

2 - Imedix Limited

47 - Industry AVG

paystructure

Pay Structure

on an average salary of £60.8k, the company has an equivalent pay structure (£60.8k)

£60.8k - Imedix Limited

£60.8k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £577.7k, this is equally as efficient (£579.9k)

£577.7k - Imedix Limited

£579.9k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 91 days, this is later than average (59 days)

91 days - Imedix Limited

59 days - Industry AVG

creditordays

Creditor Days

There is insufficient data available for this Key Performance Indicator!

- - Imedix Limited

- - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 6 days, this is less than average (52 days)

6 days - Imedix Limited

52 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (9 weeks)

0 weeks - Imedix Limited

9 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 45.6%, this is a lower level of debt than the average (62.7%)

45.6% - Imedix Limited

62.7% - Industry AVG

IMEDIX LIMITED financials

EXPORTms excel logo

Imedix Limited's latest turnover from April 2018 is estimated at £1.2 million and the company has net assets of £196.3 thousand. According to their latest financial statements, Imedix Limited has 2 employees and maintains cash reserves of £55 as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Apr 2018Apr 2017Apr 2016Apr 2015Apr 2014Apr 2013
Turnover1,155,4202,535,3521,421,0691,821,965142,69129,691
Other Income Or Grants
Cost Of Sales849,1611,869,0211,048,8611,325,684106,24922,333
Gross Profit306,259666,331372,208496,28136,4427,358
Admin Expenses337,687601,002308,398411,830-41,8547,873
Operating Profit-31,42865,32963,81084,45178,296-515
Interest Payable4,2801,81542
Interest Receivable1540923613394
Pre-Tax Profit-35,69363,55463,86184,81378,635-511
Tax-12,075-12,772-16,962-16,513
Profit After Tax-35,69351,47951,08967,85062,122-511
Dividends Paid
Retained Profit-35,69351,47951,08967,85062,122-511
Employee Costs121,650108,43144,077168,18641,30440,405
Number Of Employees221411
EBITDA*-26,13571,90166,68786,63579,979-515

* Earnings Before Interest, Tax, Depreciation and Amortisation

Apr 2018Apr 2017Apr 2016Apr 2015Apr 2014Apr 2013
Tangible Assets15,88319,7148,6326,5555,0471,348
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets15,88319,7148,6326,5555,0471,348
Stock & work in progress15,23131,375819,517412,6772,3002,000
Trade Debtors290,925887,99254,635128,35921,732
Group Debtors
Misc Debtors38,884204,6315,838
Cash556,03826,35710,627133,8911,693
misc current assets
total current assets345,0951,130,036906,347551,663157,9233,693
total assets360,9781,149,750914,979558,218162,9705,041
Bank overdraft74,89456,7931,278
Bank loan
Trade Creditors 213,918164,810358,75531,3575,551
Group/Directors Accounts125,150
other short term finances
hp & lease commitments
other current liabilities89,746521,858568,339
total current liabilities164,640917,719734,427358,75531,3575,551
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities70,00070,000
provisions
total long term liabilities70,00070,000
total liabilities164,640917,719734,427428,755101,3575,551
net assets196,338232,031180,552129,46361,613-510
total shareholders funds196,338232,031180,552129,46361,613-510
Apr 2018Apr 2017Apr 2016Apr 2015Apr 2014Apr 2013
Operating Activities
Operating Profit-31,42865,32963,81084,45178,296-515
Depreciation5,2936,5722,8772,1841,683
Amortisation
Tax-12,075-12,772-16,962-16,513
Stock-16,144-788,142406,840410,3773002,000
Debtors-762,8141,032,150-67,886106,62721,732
Creditors-213,91849,108-193,945327,39825,8065,551
Accruals and Deferred Income-432,112-46,481568,339
Deferred Taxes & Provisions
Cash flow from operations106,793-181,55589,355-119,93367,2403,036
Investing Activities
capital expenditure-1,462-17,654-4,954-3,692-5,382-1,348
Change in Investments
cash flow from investments-1,462-17,654-4,954-3,692-5,382-1,348
Financing Activities
Bank loans
Group/Directors Accounts-125,150125,150
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities-70,00070,000
share issue11
interest-4,265-1,775503613394
cash flow from financing-129,415123,375-69,95036170,3405
cash and cash equivalents
cash-5,983-20,31915,730-123,264132,1981,693
overdraft18,10155,5151,278
change in cash-24,084-75,83414,452-123,264132,1981,693

imedix limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for imedix limited. Get real-time insights into imedix limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Imedix Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for imedix limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other undefined companies, companies in RM1 area or any other competitors across 12 key performance metrics.

imedix limited Ownership

IMEDIX LIMITED group structure

Imedix Limited has no subsidiary companies.

Ultimate parent company

IMEDIX LIMITED

08051021

IMEDIX LIMITED Shareholders

adam zafar 100%

imedix limited directors

Imedix Limited currently has 1 director, Mr Adam Zafar serving since Jul 2017.

officercountryagestartendrole
Mr Adam ZafarEngland43 years Jul 2017- Director

P&L

April 2018

turnover

1.2m

-54%

operating profit

-31.4k

0%

gross margin

26.6%

+0.85%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

April 2018

net assets

196.3k

-0.15%

total assets

361k

-0.69%

cash

55

-0.99%

net assets

Total assets minus all liabilities

imedix limited company details

company number

08051021

Type

Private limited with Share Capital

industry

46460 - Wholesale of pharmaceutical goods

incorporation date

April 2012

age

13

incorporated

UK

ultimate parent company

None

accounts

Total Exemption Full

last accounts submitted

April 2018

previous names

N/A

accountant

-

auditor

-

address

2-4 eastern road, romford, essex, RM1 3PJ

Bank

-

Legal Advisor

-

imedix limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to imedix limited.

imedix limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for IMEDIX LIMITED. This can take several minutes, an email will notify you when this has completed.

imedix limited Companies House Filings - See Documents

datedescriptionview/download